中国中医药信息杂志
中國中醫藥信息雜誌
중국중의약신식잡지
CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE
2014年
1期
26-29
,共4页
高文艳%张援%林一帆%麻树人%杨卓%巩阳%王长洪%刘俊丽
高文豔%張援%林一帆%痳樹人%楊卓%鞏暘%王長洪%劉俊麗
고문염%장원%림일범%마수인%양탁%공양%왕장홍%류준려
中药%离子导入%胰胆管造影术%高淀粉酶血症%胰腺炎
中藥%離子導入%胰膽管造影術%高澱粉酶血癥%胰腺炎
중약%리자도입%이담관조영술%고정분매혈증%이선염
Chinese medicine ion introduction%endoscopic retrograde cholangio pancreatography%hyperamylasemia%pancreatitis
目的:观察中药穴位外敷离子导入防治内镜逆行胰胆管造影(ERCP)术后高淀粉酶血症和胰腺炎的临床疗效。方法将300例ERCP术后患者随机分入治疗组和对照组,术后均给予常规治疗,治疗组加用中药穴位外敷离子导入。观察2组患者ERCP术后高淀粉酶血症和胰腺炎发生率及合并胰腺炎或胰高淀粉酶血症患者血清淀粉酶恢复至正常的天数,并对术后患者腹痛进行评分。结果剔除符合剔除标准的病例17例,治疗组纳入142例,对照组141例。治疗组术后高淀粉酶血症或胰腺炎的发生例数均少于对照组,但差异无统计学意义(P>0.05);术后治疗组和对照组合并胰腺炎患者的淀粉酶恢复正常时间分别为(4.25±0.95)d 和(5.28±1.11)d,差异无统计学意义(P>0.05);术后治疗组和对照组合并胰高淀粉酶血症患者的淀粉酶恢复正常时间分别为(2.88±0.78)d 和(3.81±1.62)d,2组比较差异有统计学意义(P<0.05)。治疗组和对照组术后患者腹痛评分分别为(0.95±1.04)分和(1.21±1.12)分,2组比较差异有统计学意义(P<0.05)。结论中药穴位外敷离子导入能促进ERCP术后合并高淀粉酶血症患者血清淀粉酶的恢复,并能较好地缓解术后腹痛症状。
目的:觀察中藥穴位外敷離子導入防治內鏡逆行胰膽管造影(ERCP)術後高澱粉酶血癥和胰腺炎的臨床療效。方法將300例ERCP術後患者隨機分入治療組和對照組,術後均給予常規治療,治療組加用中藥穴位外敷離子導入。觀察2組患者ERCP術後高澱粉酶血癥和胰腺炎髮生率及閤併胰腺炎或胰高澱粉酶血癥患者血清澱粉酶恢複至正常的天數,併對術後患者腹痛進行評分。結果剔除符閤剔除標準的病例17例,治療組納入142例,對照組141例。治療組術後高澱粉酶血癥或胰腺炎的髮生例數均少于對照組,但差異無統計學意義(P>0.05);術後治療組和對照組閤併胰腺炎患者的澱粉酶恢複正常時間分彆為(4.25±0.95)d 和(5.28±1.11)d,差異無統計學意義(P>0.05);術後治療組和對照組閤併胰高澱粉酶血癥患者的澱粉酶恢複正常時間分彆為(2.88±0.78)d 和(3.81±1.62)d,2組比較差異有統計學意義(P<0.05)。治療組和對照組術後患者腹痛評分分彆為(0.95±1.04)分和(1.21±1.12)分,2組比較差異有統計學意義(P<0.05)。結論中藥穴位外敷離子導入能促進ERCP術後閤併高澱粉酶血癥患者血清澱粉酶的恢複,併能較好地緩解術後腹痛癥狀。
목적:관찰중약혈위외부리자도입방치내경역행이담관조영(ERCP)술후고정분매혈증화이선염적림상료효。방법장300례ERCP술후환자수궤분입치료조화대조조,술후균급여상규치료,치료조가용중약혈위외부리자도입。관찰2조환자ERCP술후고정분매혈증화이선염발생솔급합병이선염혹이고정분매혈증환자혈청정분매회복지정상적천수,병대술후환자복통진행평분。결과척제부합척제표준적병례17례,치료조납입142례,대조조141례。치료조술후고정분매혈증혹이선염적발생례수균소우대조조,단차이무통계학의의(P>0.05);술후치료조화대조조합병이선염환자적정분매회복정상시간분별위(4.25±0.95)d 화(5.28±1.11)d,차이무통계학의의(P>0.05);술후치료조화대조조합병이고정분매혈증환자적정분매회복정상시간분별위(2.88±0.78)d 화(3.81±1.62)d,2조비교차이유통계학의의(P<0.05)。치료조화대조조술후환자복통평분분별위(0.95±1.04)분화(1.21±1.12)분,2조비교차이유통계학의의(P<0.05)。결론중약혈위외부리자도입능촉진ERCP술후합병고정분매혈증환자혈청정분매적회복,병능교호지완해술후복통증상。
Objective To observe the clinical effects of external application of Chinese medicine ion introduction through acupiont in the prevention and treatment of hyperamylasemia and pancreatitis following endoscopic retrograde cholangio pancreatography (ERCP). Methods Three hundred subjects were divided into treatment group and control group randomly, and treated with routine therapy after surgery, moreover, treatment group was treated with external application of Chinese medicine ion introduction through acupiont. The incidence of hyperamylasemia and pancreatitis, the time of serum amylase returned to normal in patients with hyperamylasemia and pancreatitis was observed, and the abdominal pain after ERCP was scored. Results Excluding 17 cases according to the exclusion criteria, the treatment group included 142 cases and the control group included 141 cases. The hyperamylasemia and pancreatitis happened less frequently in the treatment group than in control group, but there was no significant difference (P>0.05). The time of serum amylase returned to normal in patients with pancreatitis was (4.25±0.95)d in treatment group and (5.28±1.11)d in control group, with no significant difference (P>0.05). The time of serum amylase returned to normal in patients with hyperamylasemia was (2.88 ± 0.78)d in treatment group and (3.81±1.62)d in control group, showed a significant difference (P<0.05). The score of abdominal pain was 0.95±1.04 in treatment group and 1.21±1.12 in control group, showed a significant difference (P<0.05). Conclusion External application of Chinese medicine ion introduction through acupoint can promote the recovery of the patients postoperative ERCP combined with hyperamylasemia or pancreatitis, and can better alleviate abdominal pain.